Penumbra (PEN) Net Margin (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -358.00 |
| Dec 31, 2025 | -65.00 |
| Sep 30, 2025 | -42.00 |
| Jun 30, 2025 | 122.00 |
| Mar 31, 2025 | 144.00 |
| Dec 31, 2024 | 88.00 |
| Sep 30, 2024 | 2,989.00 |
| Jun 30, 2024 | -2,405.00 |
| Mar 31, 2024 | -1,509.00 |
| Dec 31, 2023 | 1,565.00 |
| Sep 30, 2023 | -385.00 |
| Jun 30, 2023 | 371.00 |
| Mar 31, 2023 | 179.00 |
| Dec 31, 2022 | 282.00 |
| Sep 30, 2022 | 71.00 |
| Jun 30, 2022 | -181.00 |
| Mar 31, 2022 | 1,211.00 |
| Dec 31, 2021 | -1,922.00 |
| Sep 30, 2021 | 264.00 |
| Jun 30, 2021 | -468.00 |
| Mar 31, 2021 | 539.00 |
| Dec 31, 2020 | 855.00 |
| Sep 30, 2020 | 597.00 |
| Jun 30, 2020 | -1,196.00 |
| Mar 31, 2020 | -535.00 |
| Dec 31, 2019 | -157.00 |
| Sep 30, 2019 | -387.00 |
| Jun 30, 2019 | 385.00 |
| Mar 31, 2019 | 299.00 |
| Dec 31, 2018 | 2,432.00 |
| Sep 30, 2018 | -3,132.00 |
| Jun 30, 2018 | 686.00 |
| Mar 31, 2018 | -411.00 |
| Dec 31, 2017 | 917.00 |
| Sep 30, 2017 | 222.00 |
| Jun 30, 2017 | 231.00 |
| Mar 31, 2017 | -96.00 |
| Dec 31, 2016 | -2,100.00 |
| Sep 30, 2016 | 1,309.00 |
| Jun 30, 2016 | 67.00 |
| Mar 31, 2016 | 95.00 |
| Dec 31, 2015 | 245.00 |
| Sep 30, 2015 | 185.00 |
| Jun 30, 2015 | -260.00 |
| Mar 31, 2015 | 106.00 |
| Dec 31, 2014 | 390.00 |
| Sep 30, 2014 | -393.00 |
| Jun 30, 2014 | -81.00 |